Log In
Print
BCIQ
Print
Print this Print this
 

FX006

  Manage Alerts
Collapse Summary General Information
Company Flexion Therapeutics Inc.
DescriptionSustained-release intra-articular formulation of triamcinolone acetonide
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationOsteoarthritis
Indication DetailsTreat osteoarthritis (OA) of the knee
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today